drugset / Trial / NCT05373355
Safety and Efficacy of TLL018 in Patients With Chronic Spontaneous Urticaria.
RandomizedParallel-groupDouble-blindOther
Summary
This study is a randomized, double-blind, placebo-controlled, multicenter clinical trial of about 36 subjects with moderate to severe Chronic Spontaneous Urticaria.
Timeline
- Start
- 2022-05-10
- Primary completion
- 2023-09-07
- Completion
- 2023-09-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TLL018 | Unknown | 1 unknown | Oral |
| Subject | TLL018 | Unknown | 3 unknown | Oral |